Myeloid-derived suppressor cells in colorectal cancer: mechanisms of immunosuppression, therapy resistance and therapeutic targeting
Haoyi Zhang, Wenyue Liu, Yutong Zhang, Shuchen Chen, Gongping Sun · 2026
Read Myeloid-derived suppressor cells in colorectal cancer: mechanisms of immunosuppression, therapy resistance and therapeutic targeting by Haoyi Zhang, Wenyue Liu, Yutong Zhang, Shuchen Chen, Gongping Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13350317.txt.
Description
Haoyi Zhang and colleagues reviewed suppressor immune cells in colorectal cancer in a 2026 article. These myeloid-derived suppressor cells blunt the killer cells that immunotherapy tries to unleash, one reason checkpoint drugs help few bowel cancer patients, especially the common stable subtype.
Tumour genetics, gut microbes, inflammation, metabolic stress, and treatment itself all expand these cells. Beyond blocking immunity, they feed blood vessel growth, break barriers, remodel tissue, and prepare sites for spread. Firming up how to define and count them in people is a key hurdle. The review argues they are a central target for making immunotherapy work in this cancer.
Catalog record
| CREATOR | Haoyi Zhang, Wenyue Liu, Yutong Zhang, Shuchen Chen, Gongping Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69623 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |